← Leaderboards
Steven B Abramson
New York University School Of Medicine
$15,320,758
Attributed
$18,580,881
Total exposure
16
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,580,881 · 16
By mechanism
R01$11,009,419 · 5
RC2$3,994,224 · 1
T32$2,358,786 · 1
R21$816,237 · 2
U01$334,600 · 1
M01$67,615 · 6
Top collaborators
- Rany Condos3 shared
- Dan R Littman2 shared
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Rany Condos$1,360,254
- Paolo Mignatti$4,587,864
- Gregory Chang$9,023,704
Others in their field
Top investigators on “Gene Expression”
- Jeffrey P Krischer · University Of South Florida$137,481,663
- Eric S Lander · Whitehead Institute For Biomedical Res$128,154,716
- Stacey Gabriel · Massachusetts Institute Of Technology$86,302,566
- Bruce W Stillman · Cold Spring Harbor Laboratory$82,324,317
- Michael P Snyder · Yale University$75,701,723
- Ronald G Crystal · Weill Medical College Of Cornell Univ$74,774,977
Research focus
Gene ExpressionAffectDisease ProgressionCartilageInsightJointsGenesDegenerative PolyarthritisDesignBasePathway InteractionsGrantFutureTissuesPathogenesisGeneticInflammatoryCohortCharacteristicsPlayTechnologyPeripheral BloodLeukocytesPhenotype
Grant awards (54)
Genetic and Immuno-inflammatory Drivers of Post-acute Pulmonary Sequelae of SARS-CoV-2$841,864
R01 · FY2025 · HL · contact PI
Genetic and Immuno-inflammatory Drivers of Post-acute Pulmonary Sequelae of SARS-CoV-2$830,331
R01 · FY2024 · HL · contact PI
Genetic and Immuno-inflammatory Drivers of Post-acute Pulmonary Sequelae of SARS-CoV-2$853,827
R01 · FY2023 · HL · contact PI
Regulation of Inflammation by IL1RN polymorphisms$184,586
R21 · FY2022 · AR · contact PI
Regulation of Inflammation by IL1RN polymorphisms$223,740
R21 · FY2021 · AR · contact PI
Control of bone homeostasis by MT1-MMP signaling$185,311
R21 · FY2017 · AR · contact PI
Leukocyte Gene Expression and Genetic Biomarkers of OA Incidence and Progression$690,808
R01 · FY2016 · AR · contact PI
Control of bone homeostasis by MT1-MMP signaling$222,600
R21 · FY2016 · AR · contact PI
Leukocyte Gene Expression and Genetic Biomarkers of OA Incidence and Progression$697,850
R01 · FY2015 · AR · contact PI
Leukocyte Gene Expression and Genetic Biomarkers of OA Incidence and Progression$684,721
R01 · FY2014 · AR · contact PI
Regulation of chondrocytes by extracellular matrix protein.$188,879
R01 · FY2014 · AR · contact PI
Leukocyte Gene Expression and Genetic Biomarkers of OA Incidence and Progression$48,819
R01 · FY2014 · AR · contact PI
Leukocyte Gene Expression and Genetic Biomarkers of OA Incidence and Progression$681,007
R01 · FY2013 · AR · contact PI
Regulation of chondrocytes by extracellular matrix protein.$344,336
R01 · FY2013 · AR · contact PI
Regulation of chondrocytes by extracellular matrix protein.$137,334
R01 · FY2013 · AR · contact PI
Leukocyte Gene Expression and Genetic Biomarkers of OA Incidence and Progression$35,680
R01 · FY2013 · AR · contact PI
Leukocyte Gene Expression and Genetic Biomarkers of OA Incidence and Progression$782,244
R01 · FY2012 · AR · contact PI
Regulation of chondrocytes by extracellular matrix protein.$362,459
R01 · FY2012 · AR · contact PI
Regulation of chondrocytes by extracellular matrix protein.$323,005
R01 · FY2011 · AR · contact PI
Role of oral and intestinal microbiota in Rheumatoid Arthritis$1,998,164
RC2 · FY2010 · AR · contact PI
Regulation of chondrocytes by extracellular matrix protein.$336,946
R01 · FY2010 · AR · contact PI
Arthritis Training Grant$237,888
T32 · FY2010 · AR · contact PI
Role of oral and intestinal microbiota in Rheumatoid Arthritis$1,996,060
RC2 · FY2009 · AR · contact PI
Regulation of chondrocytes by extracellular matrix protein.$371,916
R01 · FY2009 · AR · contact PI
Leukocyte Gene Expression in Osteoarthritis$306,642
R01 · FY2009 · AR · contact PI
Arthritis Training Grant$202,741
T32 · FY2009 · AR · contact PI
Leukocyte Gene Expression in Osteoarthritis$306,642
R01 · FY2008 · AR · contact PI
Arthritis Training Grant$236,244
T32 · FY2008 · AR · contact PI
LEUKOCYTE GENE EXPRESSION IN OSTEOARTHRITIS$29,923
M01 · FY2008 · RR · contact PI
Leukocyte Gene Expression in Osteoarthritis$272,849
R01 · FY2007 · AR · contact PI
Arthritis Training Grant$231,342
T32 · FY2007 · AR · contact PI
LEUKOCYTE GENE EXPRESSION IN OSTEOARTHRITIS$26,432
M01 · FY2007 · RR · contact PI
Leukocyte Gene Expression in Osteoarthritis$279,923
R01 · FY2006 · AR · contact PI
Arthritis Training Grant$255,998
T32 · FY2006 · AR · contact PI
LEUKOCYTE GENE EXPRESSION IN OSTEOARTHRITIS$7,481
M01 · FY2006 · RR · contact PI
TRANSCRIPTOME-BASED BIOMARKERS IN HUMAN OSTEOARTHRITIS$1,870
M01 · FY2006 · RR · contact PI
COX-2 EICOSANOIDS IN ARTHRITIS$244,807
R01 · FY2005 · AR
ARTHRITIS TRAINING GRANT$243,859
T32 · FY2005 · AR
COX-2 EICOSANOIDS IN ARTHRITIS$40,193
R01 · FY2005 · AR
Leukocyte Gene Expression in Osteoarthritis$6,048
R01 · FY2005 · AR
TRANSCRIPTOME-BASED BIOMARKERS IN HUMAN OSTEOARTHRITIS$1,909
M01 · FY2005 · RR
COX-2 EICOSANOIDS IN ARTHRITIS$285,000
R01 · FY2004 · AR
ARTHRITIS TRAINING GRANT$247,037
T32 · FY2004 · AR
Transcriptome-based biomarkers in Human Osteoarthritis$187,100
U01 · FY2004 · AR
COX-2 EICOSANOIDS IN ARTHRITIS$285,000
R01 · FY2003 · AR
ARTHRITIS TRAINING GRANT$224,874
T32 · FY2003 · AR
Transcriptome-based biomarkers in Human Osteoarthritis$147,500
U01 · FY2003 · AR
COX-2 EICOSANOIDS IN ARTHRITIS$285,000
R01 · FY2002 · AR
ARTHRITIS TRAINING GRANT$245,197
T32 · FY2002 · AR
COX-2 EICOSANOIDS IN ARTHRITIS$317,633
R01 · FY2001 · AR
ARTHRITIS TRAINING GRANT$233,606
T32 · FY2001 · AR
SEROLOGICALLY ACTIVE, CLINICALLY STABLE SLE$167,656
R01 · FY2000 · AR
CLINICALLY STABLE SYSTEMIC LUPUS ERYTHEMATOSUS$0
M01 · FY2000 · RR
CLINICALLY STABLE SYSTEMIC LUPUS ERYTHEMATOSUS$0
M01 · FY2000 · RR